Malignancy Risk of Mycophenolate Mofetil and Azathioprine in Fibrotic ILD
Are patients with fibrotic interstitial lung disease at risk of malignancy when treated with the immunomodulatory drugs MMF and AZA?
Interstitial Lung Disease
Diagnosing Interstitial Lung Disease: A Comparison of 3 Biopsy Methods
Ttransbronchial lung cryobiopsy is a less invasive method for diagnosing interstitial lung disease; how does it compare with other ILD biopsy methods?
Do Antifibrotics Reduce Mortality, Exacerbations in Idiopathic Pulmonary Fibrosis?
A systematic review examined the effect of nintedanib and pirfenidone therapy on mortality and acute exacerbations in idiopathic pulmonary fibrosis.
Early Identification of Idiopathic Pulmonary Fibrosis From iUIP CT Patterns
How often does the CT pattern “indeterminate for usual interstitial pneumonia” indicate early IPF, and what influences progression to IPF?
Can BMI and Weight Loss Predict Mortality in Fibrotic Interstitial Lung Disease?
Researchers assessed whether BMI and weight loss are reliable prognostic indicators in patients with fibrotic interstitial lung disease.
Adverse Pregnancy Outcomes Rare in Women With ILD From Autoimmune Disorder
Researchers examined maternal risks of pregnancy in the largest-to-date cohort of women with ILD secondary to an autoimmune disorder.
Do Fine Crackles on Chest Auscultation Indicate Idiopathic Pulmonary Fibrosis?
Can fine crackles on chest auscultation be used for early diagnosis of idiopathic pulmonary fibrosis and other interstitial lung diseases?
Pulmonologists vs Rheumatologists: Treating Rheumatoid Arthritis-Associated Interstitial Lung Disease
Rheumatologists and pulmonologists provide differing perspectives on risk factors, disease assessment, and treatment strategies for patients with rheumatoid arthritis-associated interstitial lung disease.
Nintedanib Found to Slow Progression of Fibrosing Interstitial Lung Disease
Researchers assessed the effect of nintedanib on changes in FVC% predicted in a 52-week study period.
Pulmonary Rehab for Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis
A review of 21 studies evaluated the long-term outcomes associated with pulmonary rehabilitation for patients with pulmonary fibrosis, including ILD.
- Loading...
Loading...
Next post in Restrictive Lung Disease
Loading... 
Loading...